Two Versus One Week Breast Radiotherapy (RT)

Recruiting now · Phase 3

Conditions studied: Breast Cancer

In brief

This study is comparing two different radiation therapy approaches for early breast cancer to see which one is better for patients. One group will receive radiation over one week (based on the FAST-FORWARD trial), and the other group will receive radiation over two weeks with an extra focused dose (called a "concomitant boost"). The study will look at how the treatments affect side effects, breast appearance, and cancer control in the breast. It also aims to find out if the two-week treatment does a better job at preventing cancer from coming back in the breast over the long term.

Key facts

Study ID
NCT06960707
Run by
Weill Medical College of Cornell University
People needed
400
Starts
2025-04-29
Expected to finish
2040-12-31
Last updated by the study team
2026-06-15

Who can join

Age: any. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.